针对固体瘤的益生菌引导的CAR-T细胞
Rosa L Vincent1, Candice R Gurbatri1, Fangda Li2
1Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
概括
工程细菌为瘤提供合成点,引导仿真抗原受体 (CAR) - T细胞杀死抗原无关的癌细胞. 在临床前的癌症模型中,这种益生菌导向的CAR-T细胞疗法 (ProCAR) 是有前途的.
科学领域:
- 癌症学
- 微生物学
- 免疫疗法
背景情况:
- 针对固体瘤的治疗因瘤异质性和缺乏特定抗原而面临挑战.
- 细菌可以选择性地殖民瘤,并作为工程治疗交付平台.
研究的目的:
- 开发一种结合益生菌和CAR-T细胞用于向癌症治疗的新平台.
- 在固体瘤中克服抗原特异向的局限性.
主要方法:
- 为了释放合成瘤目标,
- 开发了益生菌引导的CAR-T细胞 (ProCARs) 用于在位瘤标记和溶解.
- 在人类和小鼠癌症的异种移植和同源模型中测试了ProCARs.
- 合成的益生菌可同时释放化学基因, 增强CAR-T细胞的招募能力.
主要成果:
- ProCARs证明了CAR- T细胞的激活和抗原无关的瘤细胞溶解.
- 该系统在多种临床前癌症模型中安全有效.
- 多功能益生菌增强了CAR- T细胞的招募和治疗反应.
结论:
- 益生菌引导的CAR-T细胞提供了针对固体瘤的可行策略.
- 这种方法可以杀死抗原独立的癌细胞,并增强免疫疗法.
- 进一步开发工程益生菌可以改善基于CAR-T细胞的癌症疗法.
相关概念视频
Tumor Immunotherapy
539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


